Callodine Capital Management’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.3M Sell
1,008,609
-68,882
-6% -$4.16M 4.07% 6
2026
Q1
$63M Buy
1,077,491
+397,114
+58% +$23.5M 4.41% 5
2025
Q4
$38.5M Buy
680,377
+72,577
+12% +$3.96M 3.09% 11
2025
Q3
$32.3M Buy
607,800
+80,300
+15% +$4.36M 2.83% 12
2025
Q2
$25M Buy
+527,500
New +$23.4M 2.59% 14

Other funds holding BTI

Callodine Capital Management's BTI Position: Q2 2026 in Review

Callodine Capital Management reduced its British American Tobacco (BTI) stake by 6.4% in Q2 2026, selling an estimated $4.16M and leaving 1,008,609 shares worth $62.3M. The position accounts for 4.07% of the portfolio, ranked #6.

Callodine Capital Management first reported a position in BTI in Q2 2025 and has held it in 5 quarters since. The position peaked at $63M in Q1 2026. 904 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Callodine Capital Management held 1,008,609 shares of British American Tobacco worth $62.3M as of Q2 2026.
  • Callodine Capital Management sold 68,882 British American Tobacco shares in Q2 2026, an estimated $4.16M.
  • British American Tobacco made up 4.07% of Callodine Capital Management's portfolio in Q2 2026, its #6 holding.
  • Callodine Capital Management first reported a position in British American Tobacco in Q2 2025 and has held it in 5 quarters since.
  • Callodine Capital Management's British American Tobacco position peaked at $63M in Q1 2026.
  • 904 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Callodine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.